(Total Views: 487)
Posted On: 08/09/2018 2:52:55 PM
Post# of 1460
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results,
Fletch
August 9, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – August 9, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease,…
NEW YORK (AP) _ Anavex Life Sciences Corp. (AVXL) on Thursday reported a loss of $2.8 million in its fiscal third quarter.
On a per-share basis, the New York-based company said it had a loss of 6 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The company's shares closed at $2.90. A year ago, they were trading at $3.74.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVXL at https://www.zacks.com/ap/AVXL
More on this at:
https://finance.yahoo.com/news/anavex-life-sc...00231.html
Fletch
August 9, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – August 9, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease,…
NEW YORK (AP) _ Anavex Life Sciences Corp. (AVXL) on Thursday reported a loss of $2.8 million in its fiscal third quarter.
On a per-share basis, the New York-based company said it had a loss of 6 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The company's shares closed at $2.90. A year ago, they were trading at $3.74.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVXL at https://www.zacks.com/ap/AVXL
https://finance.yahoo.com/news/anavex-life-sc...00231.html
(1)
(0)
